Edgewise Therapeutics Inc (NASDAQ:EWTX) stock is trading 217.38 percent above its 52-week low
Piper Sandler raised the price target for the Edgewise Therapeutics Inc (NASDAQ:EWTX) stock to “an Overweight”. The rating was released on March 07, 2024, according to finviz. The research report from Goldman has downgraded the stock from Neutral to Sell, with a price target set at $5. The stock was initiated by RBC Capital Mkts, […]
A Real Picture of Edgewise Therapeutics Inc (EWTX) Stock: The Fundamentals
Piper Sandler raised the price target for the Edgewise Therapeutics Inc (NASDAQ:EWTX) stock to “an Overweight”. The rating was released on March 07, 2024, according to finviz. The research report from Goldman has downgraded the stock from Neutral to Sell, with a price target set at $5. The stock was initiated by RBC Capital Mkts, […]
Edgewise Therapeutics Inc (NASDAQ:EWTX) Stock higher 100.73% in This Year: What’s Happened?
Piper Sandler raised the price target for the Edgewise Therapeutics Inc (NASDAQ:EWTX) stock to “an Overweight”. The rating was released on March 07, 2024, according to finviz. The research report from Goldman has downgraded the stock from Neutral to Sell, with a price target set at $5. The stock was initiated by RBC Capital Mkts, […]
Edgewise Therapeutics Inc (EWTX) Stock: Pessimism is a stepping stone to opportunity
Piper Sandler raised the price target for the Edgewise Therapeutics Inc (NASDAQ:EWTX) stock to “an Overweight”. The rating was released on March 07, 2024, according to finviz. The research report from Goldman has downgraded the stock from Neutral to Sell, with a price target set at $5. The stock was initiated by RBC Capital Mkts, […]
The Technical Story of Edgewise Therapeutics Inc (EWTX) Stock
Piper Sandler raised the price target for the Edgewise Therapeutics Inc (NASDAQ:EWTX) stock to “an Overweight”. The rating was released on March 07, 2024, according to finviz. The research report from Goldman has downgraded the stock from Neutral to Sell, with a price target set at $5. The stock was initiated by RBC Capital Mkts, […]
Edgewise Therapeutics Inc (EWTX) Stock Still Strong Despite Competition
Piper Sandler raised the price target for the Edgewise Therapeutics Inc (NASDAQ:EWTX) stock to “an Overweight”. The rating was released on March 07, 2024, according to finviz. The research report from Goldman has downgraded the stock from Neutral to Sell, with a price target set at $5. The stock was initiated by RBC Capital Mkts, […]
Why Edgewise Therapeutics Inc (NASDAQ:EWTX) Stock up 5.63% in Last Week?
Piper Sandler raised the price target for the Edgewise Therapeutics Inc (NASDAQ:EWTX) stock to “an Overweight”. The rating was released on March 07, 2024, according to finviz. The research report from Goldman has downgraded the stock from Neutral to Sell, with a price target set at $5. The stock was initiated by RBC Capital Mkts, […]
Edgewise Therapeutics Inc (EWTX) Stock is Just Right Size-Neither Too Big Nor Too Small
Piper Sandler raised the price target for the Edgewise Therapeutics Inc (NASDAQ:EWTX) stock to “an Overweight”. The rating was released on March 07, 2024, according to finviz. The research report from Goldman has downgraded the stock from Neutral to Sell, with a price target set at $5. The stock was initiated by RBC Capital Mkts, […]
A Real Picture of Edgewise Therapeutics Inc (EWTX) Stock: The Fundamentals
Piper Sandler raised the price target for the Edgewise Therapeutics Inc (NASDAQ:EWTX) stock to “an Overweight”. The rating was released on March 07, 2024, according to finviz. The research report from Goldman has downgraded the stock from Neutral to Sell, with a price target set at $5. The stock was initiated by RBC Capital Mkts, […]
It’s Better to Hope for Prosperity than Become Adversary: Edgewise Therapeutics Inc (EWTX) Stock
Piper Sandler raised the price target for the Edgewise Therapeutics Inc (NASDAQ:EWTX) stock to “an Overweight”. The rating was released on March 07, 2024, according to finviz. The research report from Goldman has downgraded the stock from Neutral to Sell, with a price target set at $5. The stock was initiated by RBC Capital Mkts, […]